20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: Photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor

Biochemistry

Volumn 50, Issue 18, 2011, Pages 3840-3848

  Chen, Yuenmu ^a   Falck, John R ^b   Manthati, Vijaya L ^b   Jat, Jawahar Lal ^b   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDO GROUP; BINDING PROTEINS; CANNABINOID ANTAGONIST; CONCENTRATION-DEPENDENT; CORONARY ARTERIES; EPOXYEICOSATRIENOIC ACIDS; HIGH SIGNAL-TO-NOISE RATIO; HYPERPOLARIZATION; MEMBRANE BINDING; PHOTOAFFINITY LABELING; POTASSIUM CHANNELS; RADIOLABELING; SMOOTH MUSCLES; VASCULAR SMOOTH MUSCLES;

CELL MEMBRANES; CYTOLOGY; ELECTROPHORESIS; FADING (RADIO); MEMBRANES; MUSCLE; POTASSIUM; SIGNAL TO NOISE RATIO;

ENDOTHELIAL CELLS;

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 14,15 EPOXYEICOSATRIENOIC ACID RECEPTOR; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 20 IODO 14,15 EPOXYEICOSA 8 ENOYL 3 AZIDOPHENYLSULFONAMIDE; 5 OXOEICOSATETRAENOIC ACID; 8,9 DIHYDROXYEICOSATRIENOIC ACID; ICOSATRIENOIC ACID; MICONAZOLE; NALOXONE; RECEPTOR; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN U937; CONTROLLED STUDY; CORONARY ARTERY; COW; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; AZIDES; BINDING SITES; CATTLE; CELL LINE; CORONARY VESSELS; ENDOTHELIAL CELLS; FATTY ACIDS, UNSATURATED; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; LIGANDS; PHOTOAFFINITY LABELS; PROTEIN BINDING; SULFONAMIDES; U937 CELLS;

BOVINAE;

EID: 79955601365     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi102070w     Document Type: Article

References (53)

1. Capdevila, J., Chacos, N., Werringloer, J., Prough, R. A., and Estabrook, R. W. (1981) Liver microsomal cytochrome P450 and the oxidative metabolism of archidonic acid Proc. Natl. Acad. Sci. U.S.A. 78, 5362-5366 (Pubitemid 12248586)
2. Fitzpatrick, F. A. and Murphy, R. C. (1988) Cytochrome P-450 metabolism of arachidonic acid: Formation and biological actions of "epoxygenase" -derived eicosanoids Pharmacol. Rev. 40, 229-241 (Pubitemid 19086990)
3. Zeldin, D. C. (2001) Epoxygenase pathways of arachidonic acid metabolism J. Biol. Chem. 276, 36059-36062
4. Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., Zeldin, D., and Liao, J. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285, 1276-1279 (Pubitemid 29398616)
5. Munzenmaier, D. H. and Harder, D. R. (2000) Cerebral microvascular endothelial cell tube formation: Role of astrocytic epoxyeicosatrienoic acid release Am. J. Physiol. 278, H1163-H1167
6. Krotz, F., Riexinger, T., Buerkle, M. A., Nithipatikom, K., Gloe, T., Sohn, H. Y., Campbell, W. B., and Pohl, U. (2003) Membrane potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids Arterioscler. Thromb. Vasc. Biol. 24, 595-600
7. Larsen, B. T., Campbell, W. B., and Gutterman, D. D. (2007) Beyond vasodilatation: Non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system Trends Pharmacol. Sci. 28, 32-38 (Pubitemid 46038535)
8. Gross, G. J., Gauthier, K. M., Moore, J., Falck, J. R., Hammock, B. D., Campbell, W. B., and Nithipatikom, K. (2008) Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous and endogenous EETs in the canine heart Am. J. Physiol. 294, H2838-H2844
9. Terashvili, M., Tseng, L. F., Wu, H. E., Narayanan, J., Hart, L. M., Falck, J. R., Pratt, P. F., and Harder, D. R. (2008) Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of β-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray J. Pharmacol. Exp. Ther. 326, 614-622
10. Campbell, W. B., Gebremedhin, D., Pratt, P. F., and Harder, D. R. (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ. Res. 78, 415-423 (Pubitemid 26072547)
11. Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., and Busse, R. (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401, 493-497 (Pubitemid 29470209)
12. Campbell, W. B. and Falck, J. R. (2007) Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49, 590-596
13. Campbell, W. B. and Fleming, I. (2010) Epoxyeicosatrienoic acids and endothelium-dependent responses Pfluegers Arch. 459, 881-895
14. Li, P.-L. and Campbell, W. B. (1997) Epoxyeicosatrienoic acids activate potassium channels in coronary smooth muscle through guanine nucleotide binding protein Circ. Res. 80, 877-884 (Pubitemid 27230063)
15. Falck, J. R., Krishna, U. M., Reddy, Y. K., Kumar, P. S., Reddy, K. M., Hittner, S. B., Deeter, C., Sharma, K. K., Gauthier, K. M., and Campbell, W. B. (2003) Comparison of the vasodilatory properties of 14,15-EET analogs: Structural requirements for dilation Am. J. Physiol. 284, H337-H349
16. Gauthier, K. M., Deeter, C., Krishna, U. M., Reddy, Y. K., Bondlela, M., Falck, J. R., and Campbell, W. B. (2002) 14,15-Epoxyeicosa-5(Z)-enoic acid: A selective epoxyeicosatrienoic acid antagonist that inhibits endothelium- dependent hyperpolarization and relaxation in coronary arteries Circ. Res. 90, 1028-1036 (Pubitemid 34633870)
17. Snyder, G. D., Krishna, U. M., Falck, J. R., and Spector, A. A. (2002) Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle Am. J. Physiol. 283, H1936-H1942
18. Widstrom, R. L., Norris, A. W., and Spector, A. A. (2001) Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein Biochemistry 40, 1070-1076 (Pubitemid 32108600)
19. Cowart, L. A., Wei, S., Hsu, M. H., Johnson, E. F., Krishna, U. M., Falck, J. R., and Capdevila, J. (2002) The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands J. Biol. Chem. 20, 35105-35112
20. Liu, Y., Zhang, Y., Schmelzer, K., Lee, T.-S., Fang, X., Zhu, Y., Spector, A. A., Gill, S., Morisseau, C., Hammock, B. D., and Shyy, J. Y.-J. (2005) The antiinflammatory effect of laminar flow: The role of PPARI. epoxyeicosatrienoic acids and soluble epoxide hydrolase Proc. Natl. Acad. Sci. U.S.A. 102, 16747-16752 (Pubitemid 41688848)
21. Inceoglu, B., Schmelzer, K. R., Morisseau, C., Jinks, S. L., and Hammock, B. D. (2007) Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) Prostaglandins Other Lipid Mediators 82, 42-49 (Pubitemid 44880165)
22. Lu, T., Ye, D., Wang, X., Seubert, J. M., Graves, J. P., Bradbury, A., Zeldin, D. C., and Lee, H.-C. (2006) Cardiac and vascular Katp channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms J. Physiol. 575, 627-644 (Pubitemid 44270186)
23. 2 receptors in rat mesenteric artery Prostaglandins Other Lipid Mediators 93, 44-51
24. Behm, D. J., Ogbonna, A., Wu, C., Burns-Kurtis, C. L., and Douglas, S. A. (2009) Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: Identification of a novel mechanism of vasodilation J. Pharmacol. Exp. Ther. 328, 231-239
25. Wong, P. Y., Lin, K. T., Yan, Y. T., Ahern, D., Iles, J., Shen, S. Y., Bhatt, R. K., and Falck, J. R. (1993) 14(R),15(S)-Epoxyeicosatrienoic acid receptor in guinea pig mononuclear cell membranes J. Lipid Mediators Cell Signalling 6, 199-208
26. Wong, P. Y.-K., Lai, P.-S., Shen, S.-Y., Belosludtsev, Y. Y., and Falck, J. R. (1997) Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells J. Lipid Mediators Cell Signalling 16, 155-169 (Pubitemid 27285837)
27. Wong, P. Y.-K., Lai, P.-S., and Falck, J. R. (2000) Mechanism and signal transduction of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes Prostaglandina Other Lipid Mediators 62, 321-333
28. Yang, W., Holmes, B. B., Gopal, V. R., Kishore, R. V. K., Sangras, B., Yi, X.-Y., Falck, J. R., and Campbell, W. B. (2007) Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: Use for studies of metabolism and ligand binding J. Pharmacol. Exp. Ther. 321, 1023-1031 (Pubitemid 46762683)
29. 125I-14,15- epoxyeicosa-8(Z)-enoic acid J. Pharmacol. Exp. Ther. 324, 1019-1027 (Pubitemid 351397827)
30. 125Iodo-14,15-epoxyeicosa-5Z-enoic acid: A high affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site J. Pharmacol. Exp. Ther. 331, 1137-1145
31. Revtyak, G. E., Johnson, A. R., and Campbell, W. B. (1988) Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin Am. J. Physiol. 254, C8-C19
32. Campbell, W. B., Deeter, C., Gauthier, K. M., Ingraham, R. H., Falck, J. R., and Li, P.-L. (2002) 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am. J. Physiol. 282, H1656-H1664
33. Imig, J. D., Inscho, E. W., Deichmann, P. C., Reddy, K. M., and Falck, J. R. (1999) Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A Hypertension 33, 408-413 (Pubitemid 29065693)
34. Gauthier, K. M., Falck, J. R., Reddy, L. M., and Campbell, W. B. (2004) 14,15-EET analogs: Characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries Pharmacol. Res. 49, 515-524 (Pubitemid 38338661)
35. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., LeFur, G., and Caselias, P. (1993) Cannabinoid-receptor expression in human leukocytes Eur. J. Biochem. 214, 173-180 (Pubitemid 23168532)
36. Erlemann, K. R., Rokash, J., and Powell, W. S. (2004) Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxa-6,8,11,14- eicosatetraenoic acid by inflammatory cells J. Biol. Chem. 279, 40376-40384 (Pubitemid 39287625)
37. Royal, W., Leander, M. V., and Bissonnette, R. (2005) Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells J. Neurovirol. 11, 157-165 (Pubitemid 40852423)
38. Chen, J.-K., Chen, J., Imig, J. D., Wei, S., Hachey, D. L., Guthi, J. S., Falck, J. R., Capdevila, J. H., and Harris, R. C. (2008) Identification of novel endogenous cytochrome P450 arachidonate metabolites with high affinity for cannabinoid receptors J. Biol. Chem. 283, 24514-24524
39. Gross, G. J., Baker, J. E., Hsu, A. K., Wu, H. E., Falck, J. R., and Nithipatikom, K. (2010) Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts Am. J. Physiol. 298, H2201-H2207
40. Wise, A., Jupe, S. C., and Rees, S. (2004) The identification of ligands at orphan G-protein coupled receptors Annu. Rev. Pharmacol. Toxicol. 44, 43-66 (Pubitemid 38263833)
41. Im, D.-S. (2004) Discovery of new G protein-coupled receptors for lipid mediators J. Lipid Res. 45, 410-418 (Pubitemid 38337987)
42. Chen, J. K., Capdevila, J., and Harris, R. C. (2001) Cytochrome P450 epoxygenase metabolism of arachidonic acid inhibits apoptosis Mol. Cell. Biol. 21, 6322-6331 (Pubitemid 34263530)
43. Chen, J.-K., Falck, J. R., Reddy, K. M., Capdevila, J., and Harris, R. C. (1998) Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells J. Biol. Chem. 273, 29254-29261 (Pubitemid 28507627)
44. Fleming, I., Fissllthaler, B., Michaelis, U. R., Kiss, L., Popp, R., and Busse, R. (2001) The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation of vascular cells Pfluegers Arch. 442, 511-518 (Pubitemid 32673316)
45. Imig, J. D. (2005) Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am. J. Physiol. 289, F496-F503
46. Spector, A. A., Fang, X., Snyder, G. D., and Weintraub, N. L. (2004) Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function Prog. Lipid Res. 43, 55-90 (Pubitemid 37433867)
47. + channel J. Biol. Chem. 270, 22434-22439
48. Nilius, B., Vriens, J., Prenen, J., Droogmans, G., and Voets, T. (2004) TRPV4 calcium entry channel: A paradigm for gating diversity Am. J. Physiol. 286, C195-C205
49. Pfister, S. L., Kotulock, D. A., and Campbell, W. B. (1997) Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits Hypertension 29, 303-309 (Pubitemid 27074060)
50. Ca channels Circ. Res. 97, 1270-1279
51. Obinata, H., Hattori, T., Nakane, S., Tatei, K., and Izumi, T. (2005) Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A J. Biol. Chem. 280, 40676-40683 (Pubitemid 41780559)
52. Wang, J., Wu, X., Simonavicius, N., Tian, H., and Ling, L. (2006) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84 J. Biol. Chem. 281, 34457-34464 (Pubitemid 46036653)
53. Morgan, N. G. and Dhayal, S. (2009) G-protein coupled receptors mediating long chain fatty acid signalling in pancreatic β-cells Biochem. Pharmacol. 78, 1419-1427